Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices 90701 

information that will be collected will 

also strengthen CDC’s ability to monitor 

grantee progress towards stated grant 

research, training, and outreach 

objectives, provide data-driven 

technical assistance, and disseminate 

Success Stories about what is working 

to reduce unintentional and intentional 

injuries. 

To improve and innovate through 

evaluation, research, and quality 

improvement; investigate, diagnose, and 

address health hazards and root causes; 

communicate effectively to inform and 

educate; strengthen, support, and 

mobilize communities and partnerships; 

and create, champion, and implement 

policies, plans, and laws are five of the 

noted public health activities that all 

public health systems should undertake. 

CDC ICRC grantees do all of these 

activities, and the systematic collection 

of data, annually, is the best way for 

CDC to understand this work. This APR 

information collection will enable 

grantees to submit accurate, reliable, 

and timely activity and performance 

data to the CDC. 

CDC requests OMB approval for an 

estimated 231 annual burden hours. 

There is no cost to respondents other 

than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Injury Research Center (ICRC) Grantees ...... ICRC Indicators Data Collection Annual 

Progress Report.

11 1 8 

Publication Table ............................................ 11 1 8 

Success Stories Template ............................. 11 5 1 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–26779 Filed 11–15–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-25–0728; Docket No. CDC–2024– 

0095] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled National 

Notifiable Diseases Surveillance System. 

This data collection provides the official 

source of statistics in the United States 

for nationally notifiable conditions. 

DATES: CDC must receive written 

comments on or before January 17, 

2025. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0095 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road, NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

National Notifiable Diseases 

Surveillance System (NNDSS) (OMB 

Control No. 0920–0728, Exp. 3/31/ 

2027)—Revision—Office of Public 

Health Data, Surveillance, and 

Technology (OPHDST), Centers for 

Disease Control and Prevention (CDC). 


lotter on DSK11XQN23PROD with NOTICES1
90702 Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices 

Background and Brief Description 

The Public Health Services Act (42 

U.S.C. 241) authorizes CDC to 

disseminate nationally notifiable 

condition information. The National 

Notifiable Diseases Surveillance System 

(NNDSS) is based on data collected at 

the state, territorial and local levels 

because of legislation and regulations in 

those jurisdictions that require health 

care providers, medical laboratories, 

and other entities to submit healthrelated data on reportable conditions to 

public health departments. These 

reportable conditions, which include 

infectious and non-infectious diseases, 

vary by jurisdiction depending upon 

each jurisdiction’s health priorities and 

needs. Each year, the Council of State 

and Territorial Epidemiologists (CSTE), 

supported by CDC, determines which 

reportable conditions should be 

designated nationally notifiable or 

under standardized surveillance. 

CDC requests a three-year approval for 

a Revision for the NNDSS (OMB Control 

No. 0920–0728, Exp. 03/31/2027). This 

Revision includes requests for approval 

to: 1) receive case notification data for 

Cronobacter and Ehrlichiosis, new 

notifiable conditions; 2) receive case 

notification data for Congenital 

cytomegalovirus infection and 

Toxoplasmosis, new conditions under 

standardized surveillance; and 3) 

receive new disease-specific data 

elements for Cronobacter, Hansen’s 

Disease (Leprosy,) and Leptospirosis. 

The NNDSS currently facilitates the 

submission and aggregation of case 

notification data voluntarily submitted 

to CDC from 60 jurisdictions: public 

health departments in every U.S. state, 

New York City, Washington DC, five 

U.S. territories (American Samoa, the 

Commonwealth of Northern Mariana 

Islands, Guam, Puerto Rico, and the U.S. 

Virgin Islands), and three freely 

associated states (Federated States of 

Micronesia, the Republic of the 

Marshall Islands, and the Republic of 

Palau). This information is shared 

across jurisdictional boundaries and 

both surveillance and prevention and 

control activities are coordinated at 

regional and national levels. 

Approximately 90% of case 

notifications are encrypted and 

submitted to NNDSS electronically from 

already existing databases by automated 

electronic messages. When automated 

transmission is not possible, case 

notifications are faxed, emailed, 

uploaded to a secure network or entered 

into a secure website. All case 

notifications that are faxed or emailed 

are done so in the form of an aggregate 

weekly or annual report, not individual 

cases. These different mechanisms used 

to send case notifications to CDC vary 

by the jurisdiction and the disease or 

condition. Jurisdictions remove most 

personally identifiable information (PII) 

before data are submitted to CDC, but 

some data elements (e.g., date of birth, 

date of diagnosis, county of residence) 

could potentially be combined with 

other information to identify 

individuals. Private information is not 

disclosed unless otherwise compelled 

by law. All data are treated in a secure 

manner consistent with the technical, 

administrative, and operational controls 

required by the Federal Information 

Security Management Act of 2002 

(FISMA) and the 2010 National Institute 

of Standards and Technology (NIST) 

Recommended Security Controls for 

Federal Information Systems and 

Organizations. Weekly tables of 

nationally notifiable diseases are 

available through CDC WONDER and 

data.cdc.gov. Annual summaries of 

finalized nationally notifiable disease 

data are published on CDC WONDER 

and data.cdc.gov and disease-specific 

data are published by individual CDC 

programs. 

The burden estimates include the 

number of hours that the public health 

department uses to process and send 

case notification data from their 

jurisdiction to CDC. Specifically, the 

burden estimates include separate 

burden hours incurred for automated 

and non-automated transmissions, 

separate weekly burden hours incurred 

for modernizing surveillance systems as 

part of CDC’s Data Modernization 

Initiative (DMI) implementation, 

separate burden hours incurred for 

annual data reconciliation and 

submission, and separate one-time 

burden hours incurred for the addition 

of new diseases and data elements. The 

burden estimates for the one-time 

burden for reporting jurisdictions are for 

the addition of case notification data for 

Cronobacter and Ehrlichiosis, new 

notifiable conditions; the addition of 

case notification data for Congenital 

cytomegalovirus infection and 

Toxoplasmosis, new conditions under 

standardized surveillance; and the 

addition of new disease-specific data 

elements for Cronobacter, Hansen’s 

Disease (Leprosy) and Leptospirosis. 

CDC requests OMB approval for an 

estimated 18,414 annual burden hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

States ...................................................... Weekly (Automated) ............................... 50 52 20/60 867 

States ...................................................... Weekly (Non- automated) ...................... 10 52 2 1,040 

States ...................................................... Weekly (DMI Implementation) ................ 50 52 4 10,400 

States ...................................................... Annual ..................................................... 50 1 75 3,750 

States ...................................................... One-time Addition of Diseases and Data 

Elements.

50 1 3 150 

Territories ................................................ Weekly (Automated) ............................... 5 52 20/60 87 

Territories ................................................ Weekly, Quarterly (Non-automated) ....... 5 56 20/60 93 

Territories ................................................ Weekly (DMI Implementation) ................ 5 52 4 1,040 

Territories ................................................ Annual ..................................................... 5 1 5 25 

Territories ................................................ One-time Addition of Diseases and Data 

Elements.

5 1 3 15 

Freely Associated States ........................ Weekly (Automated) ............................... 3 52 20/60 52 

Freely Associated States ........................ Weekly, Quarterly (Non-automated) ....... 3 56 20/60 56 

Freely Associated States ........................ Annual ..................................................... 3 1 5 15 

Freely Associated States ........................ One-time Addition of Diseases and Data 

Elements.

3 1 3 9 

Cities ....................................................... Weekly (Automated) ............................... 2 52 20/60 35 

Cities ....................................................... Weekly (Non-automated) ........................ 2 52 2 208 

Cities ....................................................... Weekly (DMI Implementation) ................ 2 52 4 416 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices 90703 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Cities ....................................................... Annual ..................................................... 2 1 75 150 

Cities ....................................................... One-time Addition of Diseases and Data 

Elements.

2 1 3 6 

Total ................................................. ................................................................. .................... ........................ .................... 18,414 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–26778 Filed 11–15–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–25–24HQ] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Division of 

Diabetes Translation Programmatic & 

Participant User Experience Data 

Collection (DDTDC)’’ to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on July 26, 

2024 to obtain comments from the 

public and affected agencies. CDC 

received zero comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Division of Diabetes Translation 

Programmatic & Participant User 

Experience Data Collection (DDTDC)— 

New—National Center for Chronic 

Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The Division of Diabetes Translation 

(DDT) plays a crucial role in helping 

prevent Type 2 diabetes, reducing 

diabetes complications and disability, 

and reducing diabetes-related 

disparities across the United States. 

DDT accomplishes this by providing 

education, training, technical assistance 

(TA), and engaging in communication/ 

marketing activities for various key 

audiences. These customers include 

national, state, and local partners, 

grantees, providers (e.g., lifestyle 

coaches, diabetes educators, healthcare 

providers, health/medical and 

community-based organizations), people 

with prediabetes, diabetes and their 

family, friends, and caregivers, and 

other consumers of DDT products and 

programs. 

For DDT to be able to efficiently and 

effectively do this work and fulfill its 

mission, it needs to be able to collect 

information and feedback from intended 

audiences in a timely manner and with 

enough frequency to ensure DDT can 

deliver clear, effective, efficient, and 

appropriate customer service. This 

includes, for instance, collecting data on 

key audiences’ needs and on the reach, 

uptake, use, customer experience and 

satisfaction with DDT’s services, 

products, and related programs, 

including its education, training, TA 

and communications services and 

products. 

However, in the interest of timely 

provision of services, DDT often forgoes 

the important step of getting input from 

its key audiences on the clarity, 

efficiency, effectiveness, and 

appropriateness of the services and 

resources it develops and provides for 

them. Skipping this information 

collection step, or doing so with less 

frequency, avoids the delay involved in 

the standard OMB review process, but 

increases the risk of DDT wasting both 

time and money developing and 

providing education, training, TA, and 

communication/marketing that will not 

achieve the intended objectives and will 

be unclear, irrelevant, or not fully meet 

the needs of DDT’s audiences. It can 

also have other unintended 

consequences, such as jeopardizing the 

credibility of Federal health officials. 

The Division of Diabetes Translation 

Programmatic & Participant User 

Experience Data Collection (DDTDC) 

will enable DDT to collect the 

information they require in a timely 

manner to: 

• Provide clear, effective, efficient, 

appropriate, and timely education, 

communication, training, and technical 


lotter on DSK11XQN23PROD with NOTICES1